| Autor: |
Rutishauser, R.L., Peluso, M.J., Campbell, D.M., Williams, M.C., Taylor, J., Dee, L., Agosto-Rosario, M., Hoh, R., Deeks, S.G., Sauceda, J.A., Dubé, K., Shao, S., Ehm, A. |
| Rok vydání: |
2021 |
| DOI: |
10.17615/gkt5-5g15 |
| Popis: |
To the Editors: The SARS-CoV-2 pandemic has affected research efforts worldwide. Previously, we described our strategy to mitigate COVID-19 transmission risk during an ongoing HIV cure-related clinical trial. SARS-CoV-2 vaccines recently have been authorized for emergency use and will become available to people with HIV imminently. As a result, researchers must determine how to adjust study protocols to incorporate the likelihood that participants may be vaccinated. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
